본문 바로가기
  • Home

Clinical and Prognostic Values of REEP2 in Colorectal Cancer

  • Anatomy & Biological Anthropology
  • Abbr : Anat Biol Anthropol
  • 2025, 38(2), pp.129~134
  • DOI : 10.11637/aba.2025.38.2.129
  • Publisher : 대한체질인류학회
  • Research Area : Medicine and Pharmacy > Anatomy
  • Received : May 27, 2025
  • Accepted : June 25, 2025
  • Published : June 30, 2025

Sang-Mok Yeo 1 Lee, june chai 2 Park, Jongho 3 Lee, Jae-Ho 3

1여상목 내과의원
2계명대학교 의과대학
3계명대학교 의과대학 해부학교실

Accredited

ABSTRACT

REEP2 (Receptor Expression-Enhancing Protein 2) has been implicated in various cellular processes, but its clinical relevance in colorectal cancer in colorectal cancer (CRC) remains unclear. This study aimed to evaluate the association between REEP2 expression and clinicopathologic features, molecular correlations, and patient prognosis in colon and rectal cancers using The Cancer Genome Atlas (TCGA) data. In rectal cancer, higher REEP2 expression has statistically significant relation with venous invasion, advanced pathologic stage, advanced M stage, and advanced N stage. In colon cancer, higher REEP2 expression has statistically significant relation with lymphatic invasion, venous invasion, advanced N stage, colon mucinous adenocarcinoma type, and anatomic neoplasm. Survival analysis showed that higher REEP2 expression was significantly associated with poorer overall survival in colon cancer (p=0.020), and showed a trend toward worse prognosis in rectal cancer (p=0.078). High REEP2 expression is associated with aggressive tumor characteristics and poor survival outcomes in colorectal cancer, particularly in colon cancer. To enhance our knowledge, further studies to demonstrate the molecular pathogenesis and clinical characteristics of REEP2 gene in colorectal cancer should be needed.

Citation status

* References for papers published after 2023 are currently being built.